ArticleSignal transduction and targeted therapy2020

RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response.

Zezhong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.